Trial Profile
Immunomodulatory effect of esomeprazole antitumoral and high-dose under neoadjuvant and adjuvant in patients with melanoma in stage III. Randomized pilot study treatment vs control (EFFETTO IMMUNOMODULATORIO E ANTITUMORALE DELL'ESOMEPRAZOLO AD ALTE DOSI IN REGIME NEOADIUVANTE E ADIUVANTE IN PAZIENTI CON MELANOMA IN STADIO III. STUDIO PILOTA RANDOMIZZATO TRATTAMENTO VS CONTROLLO)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Mar 2018
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications Malignant melanoma
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms AdESOM
- 12 Mar 2018 New trial record